NMR characterization of the interaction between the C-terminal domain of interferon-γ and heparin-derived oligosaccharides

被引:28
作者
VanHaverbeke, C
Simorre, JP
Sadir, R
Gans, P
Lortat-Jacob, H
机构
[1] Inst Biol Struct, Lab Resonance Magnet Nucl, CEA, CNRS,UJF JP Ebel,UMR 5075, F-38027 Grenoble 1, France
[2] Inst Biol Struct, Lab Enzymol Mol, CEA, CNRS,UJF JP Ebel,UMR 5075, F-38027 Grenoble 1, France
关键词
heparin-derived oligosaccharide; interferon-gamma (IFN gamma); NMR spectroscopy; protein-carbohydrate interaction;
D O I
10.1042/BJ20040757
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferons are cytokines that play a complex role in the resistance of mammalian hosts to pathogens. IFNgamma (interferon-gamma) is secreted by activated T-cells and natural killer cells. IFNgamma is involved in a wide range of physiological processes, including antiviral activity, immune response, cell proliferation and apoptosis, as well as the stimulation and repression of a variety of genes. IFNgamma activity is modulated by the binding of its C-terminal domain to HS (heparan sulphate), a glycosaminoglycan found in the extracellular matrix and at the cell surface. In the present study, we analysed the interaction of isolated heparin-derived oligosaccharides with the C-terminal peptide of IFNy by NMR, in aqueous solution. We observed marked changes in the chemical shifts of both peptide and oligosaccharide compared with the free state. Our results provide evidence of a binding through electrostatic interactions between the charged side chains of the protein and the sulphate groups of heparin that does not induce specific conformation of the C-terminal part of IFNgamma. Our data also indicate that an oligosaccharide size of at least eight residues displays the most efficient binding.
引用
收藏
页码:93 / 99
页数:7
相关论文
共 28 条
  • [1] Cellular responses to interferon-gamma
    Boehm, U
    Klamp, T
    Groot, M
    Howard, JC
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 : 749 - 795
  • [2] MOLECULAR MODELING OF PROTEIN-GLYCOSAMINOGLYCAN INTERACTIONS
    CARDIN, AD
    WEINTRAUB, HJR
    [J]. ARTERIOSCLEROSIS, 1989, 9 (01): : 21 - 32
  • [3] RECOMBINANT HUMAN INTERFERON-GAMMA - DIFFERENCES IN GLYCOSYLATION AND PROTEOLYTIC PROCESSING LEAD TO HETEROGENEITY IN BATCH CULTURE
    CURLING, EMA
    HAYTER, PM
    BAINES, AJ
    BULL, AT
    GULL, K
    STRANGE, PG
    JENKINS, N
    [J]. BIOCHEMICAL JOURNAL, 1990, 272 (02) : 333 - 337
  • [4] ROLE OF THE CARBOXY-TERMINAL SEQUENCE ON THE BIOLOGICAL-ACTIVITY OF HUMAN IMMUNE INTERFERON (IFN-GAMMA)
    DOBELI, H
    GENTZ, R
    JUCKER, W
    GAROTTA, G
    HARTMANN, DW
    HOCHULI, E
    [J]. JOURNAL OF BIOTECHNOLOGY, 1988, 7 (03) : 199 - 216
  • [5] 3-DIMENSIONAL STRUCTURE OF RECOMBINANT HUMAN INTERFERON-GAMMA
    EALICK, SE
    COOK, WJ
    VIJAYKUMAR, S
    CARSON, M
    NAGABHUSHAN, TL
    TROTTA, PP
    BUGG, CE
    [J]. SCIENCE, 1991, 252 (5006) : 698 - 702
  • [6] THE MOLECULAR CELL BIOLOGY OF INTERFERON-GAMMA AND ITS RECEPTOR
    FARRAR, MA
    SCHREIBER, RD
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1993, 11 : 571 - 611
  • [7] DESIGN AND SYNTHESIS OF A HELIX HEPARIN-BINDING PEPTIDE
    FERRAN, DS
    SOBEL, M
    HARRIS, RB
    [J]. BIOCHEMISTRY, 1992, 31 (21) : 5010 - 5016
  • [8] EVIDENCE FOR CONFORMATIONAL EQUILIBRIUM OF THE SULFATED L-IDURONATE RESIDUE IN HEPARIN AND IN SYNTHETIC HEPARIN MONOSACCHARIDES AND OLIGOSACCHARIDES - NMR AND FORCE-FIELD STUDIES
    FERRO, DR
    PROVASOLI, A
    RAGAZZI, M
    TORRI, G
    CASU, B
    GATTI, G
    JACQUINET, JC
    SINAY, P
    PETITOU, M
    CHOAY, J
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1986, 108 (21) : 6773 - 6778
  • [9] H-1, C-13, AND N-15 NMR BACKBONE ASSIGNMENTS AND SECONDARY STRUCTURE OF HUMAN INTERFERON-GAMMA
    GRZESIEK, S
    DOBELI, H
    GENTZ, R
    GAROTTA, G
    LABHARDT, AM
    BAX, A
    [J]. BIOCHEMISTRY, 1992, 31 (35) : 8180 - 8190
  • [10] Structural and dynamic properties of the HIV-1 tat transduction domain in the free and heparin-bound states
    Hakansson, S
    Caffrey, M
    [J]. BIOCHEMISTRY, 2003, 42 (30) : 8999 - 9006